HC Wainwright & Co. Maintains Buy on CG Oncology, Raises Price Target to $115

Benzinga · 2d ago
HC Wainwright & Co. analyst Andres Y. Maldonado maintains CG Oncology (NASDAQ:CGON) with a Buy and raises the price target from $100 to $115.